本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ProQR Therapeutics N.V.

1.35
+0.03002.27%
盤後1.350.00000.00%16:29 EDT
成交量:50.90萬
成交額:68.99萬
市值:1.42億
市盈率:-4.04
高:1.40
開:1.35
低:1.31
收:1.32
資料載入中...
2021/11/12

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/04

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/09/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/24

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/09/16

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/31

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals